COMBIPATCH Drug Patent Profile
✉ Email this page to a colleague
When do Combipatch patents expire, and when can generic versions of Combipatch launch?
Combipatch is a drug marketed by Noven Pharms Inc and is included in one NDA.
The generic ingredient in COMBIPATCH is estradiol; norethindrone acetate. There are seventy-five drug master file entries for this compound. Ten suppliers are listed for this compound. Additional details are available on the estradiol; norethindrone acetate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Combipatch
A generic version of COMBIPATCH was approved as estradiol; norethindrone acetate by BRECKENRIDGE PHARM on April 17th, 2008.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for COMBIPATCH?
- What are the global sales for COMBIPATCH?
- What is Average Wholesale Price for COMBIPATCH?
Summary for COMBIPATCH
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Finished Product Suppliers / Packagers: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 72 |
Formulation / Manufacturing: | see details |
Drug Prices: | Drug price information for COMBIPATCH |
DailyMed Link: | COMBIPATCH at DailyMed |
![COMBIPATCH drug patent expirations Drug patent expirations by year for COMBIPATCH](/p/graph/s/t/COMBIPATCH-patent-expirations.png)
![Drug Prices for COMBIPATCH](/p/graph/drug-price/COMBIPATCH.png)
See drug prices for COMBIPATCH
![Drug Sales Revenue Trends for COMBIPATCH](/p/graph/drug-sales-revenues/COMBIPATCH.png)
Pharmacology for COMBIPATCH
Drug Class | Estrogen Progestin |
Mechanism of Action | Estrogen Receptor Agonists |
US Patents and Regulatory Information for COMBIPATCH
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Noven Pharms Inc | COMBIPATCH | estradiol; norethindrone acetate | FILM, EXTENDED RELEASE;TRANSDERMAL | 020870-001 | Aug 7, 1998 | RX | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Noven Pharms Inc | COMBIPATCH | estradiol; norethindrone acetate | FILM, EXTENDED RELEASE;TRANSDERMAL | 020870-002 | Aug 7, 1998 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for COMBIPATCH
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Noven Pharms Inc | COMBIPATCH | estradiol; norethindrone acetate | FILM, EXTENDED RELEASE;TRANSDERMAL | 020870-002 | Aug 7, 1998 | ⤷ Sign Up | ⤷ Sign Up |
Noven Pharms Inc | COMBIPATCH | estradiol; norethindrone acetate | FILM, EXTENDED RELEASE;TRANSDERMAL | 020870-002 | Aug 7, 1998 | ⤷ Sign Up | ⤷ Sign Up |
Noven Pharms Inc | COMBIPATCH | estradiol; norethindrone acetate | FILM, EXTENDED RELEASE;TRANSDERMAL | 020870-001 | Aug 7, 1998 | ⤷ Sign Up | ⤷ Sign Up |
Noven Pharms Inc | COMBIPATCH | estradiol; norethindrone acetate | FILM, EXTENDED RELEASE;TRANSDERMAL | 020870-002 | Aug 7, 1998 | ⤷ Sign Up | ⤷ Sign Up |
Noven Pharms Inc | COMBIPATCH | estradiol; norethindrone acetate | FILM, EXTENDED RELEASE;TRANSDERMAL | 020870-001 | Aug 7, 1998 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for COMBIPATCH
See the table below for patents covering COMBIPATCH around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Finland | 924313 | ⤷ Sign Up | |
Austria | 122240 | ⤷ Sign Up | |
Japan | H04504515 | ⤷ Sign Up | |
Hong Kong | 1006285 | ⤷ Sign Up | |
Singapore | 49331 | Solubility parameter based pvp drug delivery system and methods therefor | ⤷ Sign Up |
>Country | >Patent Number | >Title | >Estimated Expiration |
Supplementary Protection Certificates for COMBIPATCH
Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|---|
0334429 | 97C0002 | Belgium | ⤷ Sign Up | PRODUCT NAME: ESTRADIOL; NAT. REGISTRATION NO/DATE: NL 18978 19960731; FIRST REGISTRATION: SE - 11783 19930305 |
1453521 | 15C0050 | France | ⤷ Sign Up | PRODUCT NAME: ETHINYLESTRADIOL ET MELANGE DE LEVONORGESTREL ET ETHINYLESTRADIOL; NAT. REGISTRATION NO/DATE: NL 42237 20150320; FIRST REGISTRATION: SK - 17/0017/15-S 20150129 |
1453521 | 93156 | Luxembourg | ⤷ Sign Up | PRODUCT NAME: LEVONORGESTREL ET ETHINYLESTRADIOL; FIRST REGISTRATION DATE: 20150211 |
0398460 | 12/2004 | Austria | ⤷ Sign Up | PRODUCT NAME: DROSPIRENON IN KOMBINATION MIT ESTRADIOL; NAT. REGISTRATION NO/DATE: 1-25178, 1-25179 20031127; FIRST REGISTRATION: NL RVG 27505 20021211 |
1453521 | CA 2016 00016 | Denmark | ⤷ Sign Up | PRODUCT NAME: LEVONORGESTREL OG ETHINYLOESTRADIOL; NAT. REG. NO/DATE: 56336 20151105; FIRST REG. NO/DATE: SK 17/0017/15-S 20150211 |
>Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |